Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1)
- 1 December 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 376 (2) , 441-448
- https://doi.org/10.1042/bj20030650
Abstract
Human N -acetyltransferase Type I (NAT1) catalyses the acetylation of many aromatic amine and hydrazine compounds and it has been implicated in the catabolism of folic acid. The enzyme is widely expressed in the body, although there are considerable differences in the level of activity between tissues. A search of the mRNA databases revealed the presence of several NAT1 transcripts in human tissue that appear to be derived from different promoters. Because little is known about NAT1 gene regulation, the present study was undertaken to characterize one of the putative promoter sequences of the NAT1 gene located just upstream of the coding region. We show with reverse-transcriptase PCR that mRNA transcribed from this promoter (Promoter I) is present in a variety of human cell-lines, but not in quiescent peripheral blood mononuclear cells. Using deletion mutant constructs, we identified a 20 bp sequence located 245 bases upstream of the translation start site which was sufficient for basal NAT1 expression. It comprised an AP-1 (activator protein 1)-binding site, flanked on either side by a TCATT motif. Mutational analysis showed that the AP-1 site and the 3' TCATT sequence were necessary for gene expression, whereas the 5' TCATT appeared to attenuate promoter activity. Electromobility shift assays revealed two specific bands made up by complexes of c-Fos/Fra, c-Jun, YY-1 (Yin and Yang 1) and possibly Oct-1. PMA treatment enhanced expression from the NAT1 promoter via the AP-1-binding site. Furthermore, in peripheral blood mononuclear cells, PMA increased endogenous NAT1 activity and induced mRNA expression from Promoter I, suggesting that it is functional in vivo.Keywords
This publication has 34 references indexed in Scilit:
- Pharmacogenetics of the arylamine N-acetyltransferasesThe Pharmacogenomics Journal, 2002
- Functional polymorphism of the human arylamine JV-acetyltransferase type 1 gene caused by C190T and G560A mutationsPharmacogenetics, 1998
- Transcriptional Analysis of the 5′-Noncoding Region of the Human Involucrin GeneJournal of Biological Chemistry, 1996
- Purification of recombinant human N-Acetyltransferase type 1 (NAT1) expressed in E. Coli and characterization of its potential role in folate metabolismBiochemical Pharmacology, 1995
- Nomenclature for N-acetyltransferasesPharmacogenetics, 1995
- Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoterNucleic Acids Research, 1994
- Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional ExpressionDNA and Cell Biology, 1990
- Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylationNucleic Acids Research, 1989
- A simple, rapid, and sensitive DNA assay procedureAnalytical Biochemistry, 1980
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976